ArticleBMJ open ophthalmology2019

Effect of fluocinolone acetonide 0.2 μg/day implant on the decision to drive in patients with diabetic macular oedema: a report from the FAME study.

Dilraj S Grewal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.